Dawson VL - Search Results

1

Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells.

Kusama T, Spivak CE, Whiting P, Dawson VL, Schaeffer JC, Uhl GR. Kusama T, et al. Among authors: dawson vl. Br J Pharmacol. 1993 May;109(1):200-6. doi: 10.1111/j.1476-5381.1993.tb13554.x. Br J Pharmacol. 1993. PMID: 8388298 Free PMC article.

2

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Dawson VL, et al. Among authors: dawson tm. J Neurosci. 1993 Jun;13(6):2651-61. doi: 10.1523/JNEUROSCI.13-06-02651.1993. J Neurosci. 1993. PMID: 7684776 Free PMC article.

3

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.

Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Dawson TM, et al. Among authors: dawson vl. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9808-12. doi: 10.1073/pnas.90.21.9808. Proc Natl Acad Sci U S A. 1993. PMID: 7694293 Free PMC article.

4

Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures.

Dawson VL, Dawson TM, Uhl GR, Snyder SH. Dawson VL, et al. Among authors: dawson tm. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3256-9. doi: 10.1073/pnas.90.8.3256. Proc Natl Acad Sci U S A. 1993. PMID: 8097316 Free PMC article.

5

Nitric oxide: role in neurotoxicity.

Dawson VL. Dawson VL. Clin Exp Pharmacol Physiol. 1995 Apr;22(4):305-8. doi: 10.1111/j.1440-1681.1995.tb02005.x. Clin Exp Pharmacol Physiol. 1995. PMID: 7545561 Review.

6

Identification through high-throughput screening of 4'-methoxyflavone and 3',4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos.

Fatokun AA, Liu JO, Dawson VL, Dawson TM. Fatokun AA, et al. Among authors: dawson vl, dawson tm. Br J Pharmacol. 2013 Jul;169(6):1263-78. doi: 10.1111/bph.12201. Br J Pharmacol. 2013. PMID: 23550801 Free PMC article.

7

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C. Berger NA, et al. Among authors: dawson vl, dawson tm. Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.

8

Molecular mechanisms of nitric oxide actions in the brain.

Dawson TM, Dawson VL, Snyder SH. Dawson TM, et al. Among authors: dawson vl. Ann N Y Acad Sci. 1994 Nov 17;738:76-85. doi: 10.1111/j.1749-6632.1994.tb21792.x. Ann N Y Acad Sci. 1994. PMID: 7832458 Review. No abstract available.

9

Physiological and toxicological actions of nitric oxide in the central nervous system.

Dawson VL, Dawson TM. Dawson VL, et al. Among authors: dawson tm. Adv Pharmacol. 1995;34:323-42. doi: 10.1016/s1054-3589(08)61095-9. Adv Pharmacol. 1995. PMID: 8562443 Review.

10

Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance.

Nandagopal K, Dawson TM, Dawson VL. Nandagopal K, et al. Among authors: dawson vl, dawson tm. J Pharmacol Exp Ther. 2001 May;297(2):474-8. J Pharmacol Exp Ther. 2001. PMID: 11303032 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page